Esperion Therapeutics, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
ESPR on Nasdaq
Industry
Pharmaceutical Preparations
Location
3891 Ranchero Drive, Suite 150, Ann Arbor, MI

Insiders trading volume in the past year

Esperion Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Biotech Target N V 10%+ Owner $5.58M May 24, 2021
Sheldon L. Koenig President and CEO, Director $5.45M -$163K -2.91% Sep 17, 2025
Benjamin Halladay Chief Financial Officer $1.68M -$41.3K -2.4% Sep 17, 2025
Benjamin Looker General Counsel $1.43M -$26.4K -1.82% Sep 17, 2025
Joanne M. Foody Chief Medical Officer $1.03M Jul 17, 2024
Eric Warren Chief Commercial Officer $671K -$10.5K -1.54% Apr 17, 2025
Richard Bartram Chief Financial Officer $361K Mar 14, 2022
Alan Fuhrman Director $185K May 23, 2024
Gotto Antonio M Jr Md D Phil Director $181K May 23, 2024
J. Martin Carroll Director $131K May 29, 2025
Jay Shepard Director $120K May 29, 2025
Stephen Rocamboli Director $108K May 29, 2025
Nicole Vitullo Director $105K May 29, 2025
Tracy M. Woody Director $105K May 29, 2025
H. Fischer Seth Director $102K May 29, 2025
Robert E. Hoffman Director $69K May 29, 2025
Jeffrey Berkowitz Director $61.6K May 26, 2022
Daniel Janney Director $59.8K May 27, 2021
Mark E. Mcgovern Director $35.4K May 27, 2021
John Craig Thompson Director Jul 1, 2025

Recent Insider Transactions by Companies or Individuals for Esperion Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.